<DOC>
	<DOCNO>NCT02961803</DOCNO>
	<brief_summary>The primary objective trial demonstrate superiority biotin 300 mg/day placebo clinical improvement ( walk test ) patient adrenomyeloneuropathy</brief_summary>
	<brief_title>MD1003-AMN MD1003 Adrenomyeloneuropathy</brief_title>
	<detailed_description>AMN progressive multiple sclerosis share similarities include progressive spastic paraparesis secondary energy failure lead progressive axonal degeneration . Therefore , hypothesize high dos biotin might efficient patient AMN .</detailed_description>
	<mesh_term>Adrenoleukodystrophy</mesh_term>
	<mesh_term>Biotin</mesh_term>
	<criteria>ABCD1 gene mutation identify Elevated plasma VLCFA Clinical sign AMN least pyramidal sign low limbs difficulty walk EDSS score ≥ 3.5 ≤ 6.5 Normal brain MRI brain MRI showing : abnormality observe AMN patient without cerebral demyelination maximum Loes score 4 and/or stable ( ≥6 month ) cerebral demyelination without gadolinium enhancement Loes score ≤12 . Appropriate steroid replacement adrenal insufficiency present Likely able participate schedule evaluation visit complete require study procedure Signed date write informed consent participate study accordance local regulation Affiliated Health Insurance Brain MRI abnormalities Loes score &gt; 12 gadolinium enhancement Any progressive neurological disease AMN Impossibility perform walk test TUG test Patients uncontrolled hepatic disorder , renal cardiovascular disease , progressive malignancy Any new medication AMN include Fampridine initiate less 1 month prior inclusion Contraindications MRI procedure subject paramagnetic material body , aneurysm clip , pacemaker , intraocular metal cochlear implant . Inclusion another therapeutic clinical trial ALD Not easily contactable investigator case emergency capable call investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>AMN</keyword>
	<keyword>MD1003</keyword>
	<keyword>Adrenomyeloneuropathy</keyword>
	<keyword>ALD</keyword>
	<keyword>Adrenoleukodystrophy</keyword>
	<keyword>Biotin</keyword>
	<keyword>2MWT</keyword>
	<keyword>Two-minute walk test</keyword>
	<keyword>TW25</keyword>
	<keyword>Timed 25-Foot Walk</keyword>
</DOC>